Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00193115
Status:
COMPLETED
Last Update Posted:
2010-08-04
First Post:
2005-09-12
Brief Title:
Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast Cancer
Sponsor:
SCRI Development Innovations LLC
Organization:
SCRI Development Innovations LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Cancer |
Keywords: